Sepsis with Cancer is Marked by a Dysregulated Myeloid Cell Compartment: A Pilot Study [Corrigendum]

Qi W, Han J, Cao Y, et al. J Inflamm Res. 2025;18:8643—8656. The authors have advised an error was made in the author list on page 8643, specifically, the indication of which authors contributed equally to this work. The correct author list and affiliations are as follows. Wenqian Qi,1,* Junyan Han,2,3,* Yu Cao,2,3 Yu Hao,2,3 Jingjing Hao,1 Ningning Yin,1 Xuefeng Zang,4 Lei Zhao,5 Wei Chen,4 Chen Chen,2,3 Hui Zeng,2,3 Jingyuan Liu,1 Ang Li1 1Intensive Care Unit, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People’s Republic of China; 2Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China; 3Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China; 4Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China; 5Department of Critical Care Medicine, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China *These authors contributed equally to this work. The authors apologize for this error.